Skip to main content
Clinical Trials/NCT04891627
NCT04891627
Completed
Not Applicable

Usak University Faculty of Dentistry

Uşak University1 site in 1 country76 target enrollmentJanuary 6, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Periodontitis
Sponsor
Uşak University
Enrollment
76
Locations
1
Primary Endpoint
It was aimed to compare IL-34 levels by taking gingival crevicular fluid in systemic healthy, periodontitis and diabetic patients with periodontitis groups.
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Type 2 diabetes mellitus is a metabolic disorder. There is a bidirectional association between periodontal disease and DM. Currently there is no data relationship between CSF-1 and IL-34, periodontal disease and diabetes.The aim of this study to investigate GCF levels of IL-34 and CSF-1 in periodontitis subjects with diabetes.

Detailed Description

Periodontally healthy (H), periodontitis, and periodontitis with diabetes patients, were recruited for this study. 1. Inclusion criteria for H groups: Individuals with clinically healthy gingiva, no attachment and bone loss, and less than 10% bleeding on probing were included. 2. Inclusion criteria for periodontitis groups: Systemically healthy individuals with interdental CAL ≥ 5 mm and PPD ≥ 6 mm were included. 3. Inclusion criteria for periodontitis with diabetes groups: Type 2 diabetes patients with interdental CAL ≥ 5 mm, PPD ≥ 6 mm, and HbA1c ≥ 6.5% were included. The plaque index (PI), gingival index (GI), presence of bleeding on probing (BOP), PD, and clinical AL were used for clinical periodontal assessments. All assessments were done with a manual probe. GCF samples were obtained and analyzed using an enzyme-linked immunosorbent assay.

Registry
clinicaltrials.gov
Start Date
January 6, 2021
End Date
May 4, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Uşak University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • have 20 teeth
  • have diabetes .

Exclusion Criteria

  • Individuals have systemic disease
  • those using drugs;

Outcomes

Primary Outcomes

It was aimed to compare IL-34 levels by taking gingival crevicular fluid in systemic healthy, periodontitis and diabetic patients with periodontitis groups.

Time Frame: GCF samples taken within the 1. week after the clinical examination of the patient

GCF was taken interproximal region.

Secondary Outcomes

  • It was aimed to compare CSF-1 levels by taking gingival crevicular fluid in systemic healthy, periodontitis and diabetic patients with periodontitis groups.(GCF samples taken within the 1. week after the clinical examination of the patient)

Study Sites (1)

Loading locations...

Similar Trials